A groundbreaking study from the University of California, San Francisco (UCSF) has revealed the hidden scientific and industrial strategies employed by Philip Morris Companies Inc. in the creation and marketing of Lunchables, turning what seemed to be a simple children’s convenience food into one of America’s most pervasive ultra-processed food products. This research uncovers how advanced cigarette research, flavor chemistry, and behavioral science were ingeniously adapted to the food industry, reshaping children’s eating habits and fueling public health challenges.

When Philip Morris acquired General Foods in 1985, it gained ownership not just of an existing food company but of an innovative product still in development: Lunchables. This acquisition marked a critical convergence of tobacco industry expertise with food product innovation. The UCSF study, recently published in the American Journal of Public Health, provides the first comprehensive analysis of how this meld of industries engineered ultra-processed foods by applying decades of tobacco research to optimize flavor, texture, and consumer appeal, especially targeting children.

Ultra-processed foods have become a dominant force in the American food landscape, making up nearly two-thirds of caloric intake among U.S. children. These foods are characterized not by their natural ingredients but by complex formulations containing artificial additives and flavor enhancers. Clinical trials consistently demonstrate that such products promote overeating and contribute directly to the rising epidemics of childhood obesity, type 2 diabetes, and metabolic liver diseases. This study thus places Philip Morris’s strategies at the center of an industrial transformation that has long-term public health implications.

Delving into corporate archival documents, including memos and internal strategic reports released during legal processes, the research reveals how tobacco companies like Philip Morris and R.J. Reynolds deliberately ventured into the food industry in the 1980s. These companies owned major food brands such as Nabisco and Del Monte, and their entry into the food sector was not accidental but a carefully crafted business strategy designed to leverage synergies between tobacco and food product development.

Philip Morris’s merger with Kraft General Foods created North America’s largest food conglomerate, facilitating the transfer of proprietary knowledge and experimental techniques developed for cigarette design into food product engineering. This integration allowed for cross-division innovation, particularly in flavor chemistry and packaging technology, maximizing commercial returns by optimizing production efficiency while manipulating sensory experiences in ways that deepen consumer engagement and loyalty—particularly among young consumers.

A key element of the strategy was the concept of “technical synergies.” By adapting shelf-stable packaging technologies originally perfected for tobacco products, the company was able to develop innovative “grab-and-go” meal kits that preserved flavor and texture while appealing immensely to children’s preferences and parental desires for convenience. This packaging also extended product shelf life, thereby reducing costs and enabling rapid nationwide distribution.

Lunchables were particularly designed to tap into children’s behavioral and psychological drives. The product’s segmented packaging encouraged children to interact with their meal—essentially “playing” with food by assembling it according to their preferences—thereby fostering a sense of independence and control. Through vivid branding and familiar processed ingredients, such as Oscar Mayer meats and Kraft cheeses, the product also assuaged parental concerns while embedding itself as a staple in children’s diets across the country.

Intriguingly, when Philip Morris sought to introduce low-fat versions of Lunchables, they adapted neuroscience and behavioral testing techniques originally developed for nicotine research. Tobacco experts well-versed in the neural pathways of flavor perception applied electroencephalography (EEG) and sophisticated sensory tests to optimize the palatability of artificial fats and flavor additives without compromising taste. This crossover exemplifies the complex technological and scientific exchanges that fueled the surging growth of ultra-processed foods.

Laura Schmidt, PhD, the lead author of this study and a professor of medicine at UCSF, explicates that the fundamental difference between ultra-processed and minimally processed foods lies in these additives and flavor engineering technologies. The intricate manipulation of taste and sensory appeal using cigarette technology, she explains, was crucial in creating food products that go beyond mere sustenance to tap into deep neurobehavioral motivators shaping consumer choices—especially in children.

This research was facilitated by the accessibility of Philip Morris’s internal documents housed in the UCSF Industry Documents Library, which offers an unprecedented archive of millions of records across multiple sectors including tobacco, food, chemicals, and fossil fuels. Availability of these records has enabled researchers to reconstruct the corporate strategies behind the rise of ultra-processed foods and their lasting influence on public health.

Facing a wave of litigation and strengthening regulations during the 2000s, tobacco companies gradually divested from their food sector holdings by 2007, refocusing on their core business of cigarette manufacturing. Nevertheless, the ultra-processed food industry, once catalyzed by these tobacco conglomerates, continued its rapid expansion throughout the 21st century, perpetuating a cycle of public health concerns tied to diet-related diseases.

The UCSF study highlights an urgent need to consider the historical and industrial origins of ultra-processed foods when devising public health policies aimed at curbing the rising rates of obesity and metabolic disorders among children. Understanding that these products were engineered with sophisticated neurobehavioral insights borrowed from tobacco science underscores the challenge of addressing their pervasive role in contemporary diets.

By revealing how tobacco companies’ scientific expertise was redirected to engineer enticing food products for children, this research uncovers the hidden industrial forces that have shaped modern American dietary patterns, emphasizing the critical intersection of corporate strategy, neuroscience, and public health.

Subject of Research: Scientific and industrial strategies of tobacco companies applied to ultra-processed food product design, particularly focusing on Lunchables and associated public health impacts.

Article Title: Tobacco Science and Flavor Engineering: How Philip Morris Designed Lunchables to Maximize Children’s Appeal

News Publication Date: June 3, 2026

Web References:
– American Journal of Public Health Article: https://ajph.aphapublications.org/doi/epdf/10.2105/AJPH.2026.308491
– UCSF Industry Documents Library: https://www.industrydocuments.ucsf.edu/food/

References: Internal corporate documents from Philip Morris Companies Inc., legal discovery archives, and neuroscience studies on flavor perception.

Image Credits: Not available

Keywords
Tobacco, Behavioral neuroscience, Social neuroscience, Obesity, Childhood obesity, Children, Type 2 diabetes, Diabetes, Fatty liver disease, Weight gain, Brain

Our telescope expert chose the Celestron NexStar 8SE as our best overall telescope, and now, with $200 off, it makes this versatile telescope excellent value for money ahead of Prime Day.

Our telescope expert chose the Celestron NexStar 8SE as our best overall telescope, and now, with $200 off, it makes this versatile telescope excellent value for money ahead of Prime Day.

Our telescope expert chose the Celestron NexStar 8SE as our best overall telescope, and now, with $200 off, it makes this versatile telescope excellent value for money ahead of Prime Day.

The company’s RTX Spark chips might finally turn the “AI PC” into reality.

How does this third-party lens compare to the native Sony equivalent? We tested both to see whether it’s worth going native or whether you should save your money.

How does this third-party lens compare to the native Sony equivalent? We tested both to see whether it’s worth going native or whether you should save your money.

The company’s RTX Spark chips might finally turn the “AI PC” into reality.

How does this third-party lens compare to the native Sony equivalent? We tested both to see whether it’s worth going native or whether you should save your money.

In recent years, the quest for healthier animal products has driven remarkable advancements in agricultural sciences. A groundbreaking study published in Scientific Reports in 2026 introduces an innovative approach to reducing cholesterol content in egg yolks without compromising laying performance in hens. This research explores the intricate interplay of natural plant derivatives, probiotics, and fermented feed additives in optimizing poultry health and product quality, providing a promising avenue toward functional foods with enhanced nutritional profiles.

Egg yolk cholesterol has long been a nutritional concern for consumers, often limiting the intake of eggs despite their valuable protein and micronutrient content. Cholesterol, a lipid molecule essential for cellular functions, when consumed in excess, is linked to cardiovascular diseases. Therefore, reducing egg yolk cholesterol via dietary interventions in poultry is a crucial goal for animal nutritionists and food scientists. The study by Al-Khalaifah, Surrayai, Al-Musalam, and their colleagues investigates the synergistic effects of Ziziphus leaves, a well-known medicinal herb, combined with probiotics and fermented red mold rice on cholesterol metabolism and laying performance in hens.

Ziziphus leaves, derived from a genus of plants known for their bioactive compounds, contain flavonoids, saponins, and alkaloids with antioxidative and lipid-lowering properties. These phytochemicals are hypothesized to modulate lipid biosynthesis pathways in laying hens, thereby influencing yolk cholesterol deposition. The incorporation of Ziziphus leaves into hen diets aims to harness natural bioactive compounds that can interfere with cholesterol synthesis or absorption within the avian digestive system.

Probiotics, live microorganisms that confer health benefits to the host, play a vital role in maintaining gut microbiota balance. In poultry, a robust and diverse microbial ecosystem promotes optimal nutrient absorption and immune function. The study incorporates specific probiotic strains known for their cholesterol-assimilative abilities, which may degrade cholesterol in the gastrointestinal tract or prevent its absorption. The interaction between probiotics and the host metabolism is complex, involving modulation of bile salt hydrolase activity, short-chain fatty acid production, and alteration of hepatic cholesterol synthesis, all contributing factors in reducing circulating cholesterol levels.

Fermented red mold rice, a traditional Asian fermented product enriched with monacolins, particularly monacolin K, known chemically as lovastatin, exhibits potent cholesterol-lowering effects. The secondary metabolites produced during rice fermentation inhibit HMG-CoA reductase, a key enzyme in endogenous cholesterol synthesis. While widely studied in humans, its application in poultry nutrition represents a novel strategy to modulate lipid profiles in egg production. The inclusion of fermented red mold rice in feed leverages these bioactive compounds to reduce yolk cholesterol efficiently.

The research methodology involved dietary supplementation of laying hens with a combination of Ziziphus leaves, probiotics, and fermented red mold rice over a predetermined period. The investigators meticulously measured serum cholesterol levels, egg yolk cholesterol concentrations, and key parameters of laying performance, including egg production rate, egg weight, and feed conversion efficiency. This comprehensive approach ensured a holistic assessment of both health markers and productivity outcomes, essential for practical applications in commercial poultry farming.

Results demonstrated a significant reduction in egg yolk cholesterol content among hens receiving the combined dietary treatments compared to the control group. This cholesterol-lowering effect was accompanied by sustained or even improved laying performance parameters, indicating that the intervention did not exert adverse impacts on productivity. The findings underscore the potential of natural dietary additives not only to enhance egg nutritional quality but also to maintain economically viable production metrics.

Mechanistically, the study suggests that the hypocholesterolemic effect arises from the concerted actions of plant-derived bioactives inhibiting cholesterol biosynthesis enzymes, probiotics promoting cholesterol metabolism and bile acid deconjugation, and fermented red mold rice providing statin-like compounds to block endogenous cholesterol production pathways. This multifactorial model exemplifies the intricate biochemical crosstalk within the avian metabolism influenced by dietary constituents.

The implications of this research extend beyond poultry science into the broader context of functional food development and human health. By generating eggs with inherently lower cholesterol, consumers may benefit from reduced dietary cholesterol intake without sacrificing the sensory qualities and culinary versatility of eggs. This advancement also aligns with increasing consumer demand for natural, additive-free animal products and sustainable farming practices.

Future investigations could explore the long-term effects of these dietary interventions on hen health, egg sensory attributes, and consumer acceptance. Additionally, understanding the molecular signaling pathways modulated by these natural compounds in depth could pave the way for optimized formulations tailored to different poultry breeds and management conditions.

Environmental considerations are also relevant, as the use of fermented feed additives and plant-based supplements might reduce reliance on synthetic feed additives and antibiotics, promoting eco-friendly poultry production. This holistic approach integrates animal welfare, product quality, and environmental sustainability, reinforcing the significance of multidisciplinary strategies in modern agriculture.

The study’s innovative use of combined natural additives addresses a critical challenge in animal-derived food production—enhancing nutritional value while maintaining productivity. Such integrative research bridges gaps between animal physiology, microbiology, and food science, setting a precedent for future investigations into bioactive dietary interventions in livestock.

As consumers become increasingly health-conscious and environmentally aware, the poultry industry stands poised to adopt cutting-edge, science-backed feeding strategies that yield superior products. The application of Ziziphus leaves, probiotics, and fermented red mold rice epitomizes this trend, demonstrating a scientifically validated pathway to producing eggs with lower cholesterol content while supporting the hen’s physiological performance.

Moreover, this research highlights the importance of exploring underutilized natural resources, such as medicinal plants and traditional fermented foods, within the context of animal nutrition. Such resources offer vast untapped potential for enhancing livestock health and food quality through sustainable and economically feasible means.

In conclusion, the synergistic use of Ziziphus leaves, probiotics, and fermented red mold rice represents a transformative advancement in poultry nutrition, effectively reducing egg yolk cholesterol without compromising laying performance. These findings open new horizons for integrating natural bioactive compounds into animal feeds to produce functional animal-derived foods that meet modern consumer demands and promote health. Continued research and development in this domain will undoubtedly contribute to reshaping the future landscape of animal agriculture and food sciences.

---

Subject of Research: Dietary interventions using Ziziphus leaves, probiotics, and fermented red mold rice to reduce egg yolk cholesterol and sustain laying performance in hens.

Article Title: Ziziphus leaves, probiotic, and fermented red mold rice reduce egg yolk cholesterol and sustain laying performance in hens.

Article References:
Al-Khalaifah, H., Surrayai, T., Al-Musalam, M. et al. Ziziphus leaves, probiotic, and fermented red mold rice reduce egg yolk cholesterol and sustain laying performance in hens. Sci Rep (2026). https://doi.org/10.1038/s41598-026-55410-2

Image Credits: AI Generated

Sigma’s 60-600mm Sport lens is one of the most versatile wildlife lenses around, but can its huge zoom range outweigh the heavy design?

A dependable and sharp 6-inch GoTo telescope with sharp views and basic imaging potential, but with dated tech that’s a bit slow to set up.

Sigma’s 60-600mm Sport lens is one of the most versatile wildlife lenses around, but can its huge zoom range outweigh the heavy design?

Sigma’s 60-600mm Sport lens is one of the most versatile wildlife lenses around, but can its huge zoom range outweigh the heavy design?

The changes, after Meta’s legal losses in two child safety cases, are aimed at limiting harmful content shown to teenagers on Instagram, Facebook and Messenger.

In an era where neonatal care continues to evolve rapidly, a recent study published in the Journal of Perinatology has cast fresh light on an urgent pediatric health issue: the use of probiotics in preterm infants and their association with necrotizing enterocolitis (NEC). This research, led by V.N. Tolia and colleagues in 2026, revisits the impact of the 2023 FDA warning actions on clinical practice and infant health outcomes. The study meticulously dissects the changes in probiotic administration post-warning and evaluates the consequential trends in NEC incidence among the most vulnerable neonatal populations.

Necrotizing enterocolitis is a devastating gastrointestinal emergency primarily affecting preterm infants, characterized by intestinal inflammation and necrosis, which can lead to mortality or long-term morbidity. Probiotics have long been considered a promising intervention to reduce NEC rates, with numerous clinical trials advocating for their efficacy in modulating the gut microbiome, enhancing mucosal barrier function, and reducing pathogenic colonization. Despite this, the 2023 FDA warnings—rooted in concerns about product standardization, safety, and regulatory oversight—prompted a reappraisal of probiotic use in neonatal intensive care units (NICUs) across the United States.

The crux of the study by Tolia et al. involves a retrospective analysis that comprehensively compares probiotic use before and after the FDA warning. Their data were drawn from large-scale clinical registries, enabling robust statistical evaluation of treatment patterns alongside clinical outcomes in premature infants born prior to 37 weeks’ gestation. The researchers aimed to determine whether reduced probiotic exposure post-warning corresponded to any alteration in NEC incidence, thereby illuminating the real-world impact of regulatory interventions on both healthcare practices and neonatal health trajectories.

One of the study’s pivotal revelations is a significant decline in probiotic administration following the FDA’s cautionary communication. Many NICUs, previously advocates of probiotic incorporation into feeding regimens, adopted a more conservative approach in the face of regulatory uncertainty. This shift was not uniform across hospitals but reflected a broader trend towards prudence, underscoring how regulatory guidance can swiftly influence clinical decision-making, particularly for interventions with complex risk-benefit profiles.

Intriguingly, the analysis linked this reduction in probiotic usage to a concomitant uptick in NEC cases. The temporal association, while not proving causality, aligns with prior meta-analyses suggesting probiotics’ protective influence against NEC. The increase in NEC rates post-warning reignites debates within the neonatology community about balancing regulatory prudence against potential clinical benefits. This observed correlation accentuates the pivotal role probiotics may play in modulating neonatal gut health, especially when viewed against the backdrop of limited alternative preventive strategies.

The study’s methodical approach, employing controls for confounders such as gestational age, birth weight, and comorbidities, bolsters the credibility of its findings. Additionally, the researchers delve into variations in probiotic strains and formulations used prior to the FDA’s advisory, noting marked heterogeneity in practice that may have contributed to prior regulatory concerns about product consistency and safety profiles. This discussion sheds light on the underlying challenges facing probiotic therapy implementation in NICUs—challenges that extend beyond clinical efficacy to include manufacturing standards, quality control, and regulatory oversight.

The regulatory landscape for probiotics remains complex, primarily because these products straddle the line between dietary supplements and therapeutic agents. The FDA warning in 2023, focusing on adverse event reports and batch inconsistencies, highlights the difficulties in ensuring product reliability in a rapidly expanding probiotic market. Tolia et al. emphasize the necessity for rigorous clinical-grade probiotics, with stringent manufacturing practices and precise microbial characterization, to ensure both safety and efficacy for this vulnerable patient population.

Moreover, the researchers underscore the importance of ongoing pharmacovigilance and post-market surveillance to track adverse events and long-term outcomes of probiotic interventions. Their work illuminates a gap in comprehensive, longitudinal data on probiotic safety in preterm infants, a deficit that complicates clinical guidelines and regulatory policies. The study advocates for robust randomized controlled trials coupled with regulatory frameworks tailored to the unique challenges of neonatal probiotic formulations.

The findings carry significant implications for neonatologists, clinicians, and regulatory bodies alike. The evidence suggests that while caution is warranted, outright cessation or dramatic restriction of probiotic use in preterm infants may inadvertently raise NEC risks, underscoring the need for balanced, evidence-based policies. As NICU teams strive to optimize outcomes, the study calls for collaborative efforts integrating clinical research, microbiology, pharmacology, and regulatory science to develop safe, effective probiotic therapies.

Importantly, the article also explores the microbiome’s critical role in neonatal health, detailing how dysbiosis—a disrupted microbial community—precedes or accompanies NEC. Probiotics work by restoring microbiome balance, promoting beneficial bacteria such as Lactobacillus and Bifidobacterium species, and suppressing pathogenic organisms like Clostridium species. Understanding these mechanisms not only rationalizes probiotic use but also encourages precision medicine approaches that tailor microbial interventions based on individual risk profiles.

Tolia et al.’s exploration extends to ethical considerations surrounding probiotic administration and FDA regulatory actions. Parental concerns, informed consent, and the ethical imperative to provide evidence-based care merge in a complex interplay given the severity of NEC and the potential benefits and harms of probiotics. The researchers argue that transparent communication between clinicians and families, coupled with policy frameworks responsive to emerging data, is essential in navigating these ethical waters.

In the context of global neonatal health, the study’s insights resonate beyond the United States. Countries with diverse NICU practices and regulatory standards face similar challenges in implementing probiotics for NEC prevention. The authors advocate for international collaboration to harmonize probiotic quality controls, clinical guidelines, and research priorities, thereby enhancing care consistency and safety worldwide.

Finally, this research adds a significant chapter to the ongoing narrative of probiotic use in neonatology. By correlating FDA regulatory actions with clinical outcomes, it provides a rare real-world evaluation of how policy shifts translate into health impacts. The study not only charts a cautionary tale of unintended consequences but also inspires future innovation in probiotic development, regulatory science, and neonatal care strategies designed to protect our most fragile patients.

As medicine strides towards personalized neonatal care, this study reaffirms the necessity to couple scientific rigor with vigilant regulatory oversight. The dynamic between innovation and safety remains delicate, and the case of probiotics post-FDA warning embodies this tension. For clinicians, researchers, policymakers, and families alike, these findings offer crucial evidence to shape the future of NEC prevention—casting probiotics not as a simplistic solution but as a scientifically complex, clinically significant therapeutic frontier.

---

Subject of Research:
Probiotic use and its impact on necrotizing enterocolitis in preterm infants following FDA warning actions.

Article Title:
Probiotics and necrotizing enterocolitis in preterm infants after the food and drug administration warning actions.

Article References:
Tolia, V.N., Bennett, M.M., Handler, D. et al. Probiotics and necrotizing enterocolitis in preterm infants after the food and drug administration warning actions. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02712-y

Image Credits: AI Generated

DOI: 02 June 2026

The state became the first to sue the ChatGPT maker over claims that its technology posed a risk to children and that the company had failed to warn the public of dangers.

A dependable and sharp 6-inch GoTo telescope with sharp views and basic imaging potential, but with dated tech that’s a bit slow to set up.

Keychron’s K2 HE Concrete Edition sounds like a cute gimmick, but as I discovered, there’s a really solid keyboard beyond the absurd choice of materials.

Made for those who hate having a TV in the home, Samsung’s Movingstyle monitor-on-wheels brings the entertainment when you need it and hides away in a closet when you don’t.